Mortada Mohamed, Amer Yomna A, Zaghlol Rabab S
Rheumatology and Rehabilitation Department, Zagazig University, Zagazig, Egypt.
Physical Medicine and Rehabilitation Department, Security Forces Hospital, Makkah, Saudi Arabia.
Clin Med Insights Arthritis Musculoskelet Disord. 2020 Nov 10;13:1179544120967383. doi: 10.1177/1179544120967383. eCollection 2020.
The aim of the work was to demonstrate the effectiveness and safety of ultrasonographic guided aspiration performed with corticosteroid injection intra-lesional for ruptured Baker cysts (BCs).
Single-center retrospective study that included 42 patients with knee joint disorder associated with ruptured BCs were treated by ultrasonographic guided aspiration of fluid from the cyst and different points from the calf then intra-lesional injection of corticosteroids once or twice, 1 week apart. Follow up were done weekly until complete resolution of symptoms. Visual analog scale (VAS) and Rauschning-Lindgren and Lysholm Knee Scoring Scales (RLC) were used for assessment.
Clinical parameters (VAS and RLC) improved significantly in all patients at both post injection evaluation visits (1 week and 12 weeks). Ultrasonographic features improved significantly with complete disappearance of free fluid in the calf in 35 (83.3%) cases 1 week after the injection, and in 41 (97.6%) after 12 weeks. As regards BCs only 4 (9.5%) cases showed complete disappearance after 1 week and there was recurrent BCs in 38 (90.5%) cases which required reaspiration. While after 12 weeks, BCs were completely disappeared in 23 (54.8%) cases, most of the relapsed BCs were complex BCs. No side effects were reported in all cases.
Ultrasonographic guided aspiration followed by injection of corticosteroids intra-lesional is an efficient and safe method for managing ruptured BCs.
本研究旨在证明超声引导下囊肿内注射皮质类固醇激素对破裂的贝克囊肿(BCs)进行抽吸治疗的有效性和安全性。
一项单中心回顾性研究,纳入42例与破裂BCs相关的膝关节疾病患者,通过超声引导从囊肿及小腿不同部位抽吸液体,然后在病灶内注射皮质类固醇激素,每周1次,共1或2次,间隔1周。每周进行随访,直至症状完全缓解。采用视觉模拟量表(VAS)、劳施宁-林德格伦量表和 Lysholm 膝关节评分量表(RLC)进行评估。
在两次注射后评估访视(1周和12周)时,所有患者的临床参数(VAS和RLC)均有显著改善。超声特征显著改善,注射后1周,35例(83.3%)小腿游离液体完全消失,12周后41例(97.6%)消失。仅就BCs而言,1周后仅4例(9.5%)完全消失,38例(90.5%)复发,需要再次抽吸。12周后,23例(54.8%)BCs完全消失,大多数复发的BCs为复杂性BCs。所有病例均未报告副作用。
超声引导下抽吸后病灶内注射皮质类固醇激素是治疗破裂BCs的一种有效且安全的方法。